Graham Capital Management L.P. Buys New Position in The Pennant Group, Inc. (NASDAQ:PNTG)

Graham Capital Management L.P. bought a new position in shares of The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 13,821 shares of the company's stock, valued at approximately $367,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Van Berkom & Associates Inc. increased its stake in shares of The Pennant Group by 2,635.6% in the fourth quarter. Van Berkom & Associates Inc. now owns 2,198,216 shares of the company's stock valued at $58,297,000 after buying an additional 2,117,859 shares during the period. FMR LLC increased its position in The Pennant Group by 54.5% during the 4th quarter. FMR LLC now owns 3,906,327 shares of the company's stock valued at $103,596,000 after purchasing an additional 1,377,815 shares during the period. Vanguard Group Inc. raised its holdings in The Pennant Group by 11.0% during the 4th quarter. Vanguard Group Inc. now owns 2,261,564 shares of the company's stock worth $59,977,000 after purchasing an additional 223,919 shares during the last quarter. Ranger Investment Management L.P. raised its holdings in The Pennant Group by 147.3% during the 4th quarter. Ranger Investment Management L.P. now owns 195,210 shares of the company's stock worth $5,177,000 after purchasing an additional 116,285 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new position in shares of The Pennant Group in the 4th quarter worth approximately $2,570,000. 85.88% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on PNTG. Truist Financial increased their price objective on shares of The Pennant Group from $28.00 to $32.00 and gave the stock a "hold" rating in a research report on Monday, May 12th. Stephens reaffirmed an "overweight" rating and set a $38.00 price target on shares of The Pennant Group in a research report on Wednesday, April 2nd. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, The Pennant Group has a consensus rating of "Moderate Buy" and an average price target of $35.60.

The Pennant Group Trading Down 0.9%

Shares of NASDAQ:PNTG traded down $0.26 during mid-day trading on Thursday, hitting $28.37. The company had a trading volume of 7,409 shares, compared to its average volume of 223,659. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.12 and a quick ratio of 1.12. The Pennant Group, Inc. has a one year low of $21.18 and a one year high of $37.13. The firm has a fifty day moving average price of $26.07 and a 200 day moving average price of $27.20. The company has a market capitalization of $977.89 million, a PE ratio of 41.72, a price-to-earnings-growth ratio of 2.24 and a beta of 1.56.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.